As of June 5, 2025, Zosano Pharma Corp (ZSAN) reports a Current Ratio of 1.04.
Current Ratio assesses a company's ability to pay short-term debts by comparing liquid assets to liabilities, with higher ratios signaling better financial health.
Historical Trend of Zosano Pharma Corp's Current Ratio
Over recent years, Zosano Pharma Corp's Current Ratio has shown significant volatility. The table below summarizes the historical values:
| Date | Current Ratio |
|---|---|
| 2021-12-31 | 1.04 |
| 2020-12-31 | 2.46 |
| 2019-12-31 | 0.42 |
| 2018-12-31 | 2.07 |
| 2017-12-31 | 1.28 |
This slight downward trend highlights how Zosano Pharma Corp manages its short-term assets and liabilities over time.
Comparing Zosano Pharma Corp's Current Ratio to Peers
To better understand Zosano Pharma Corp's position, it's useful to compare its Current Ratio against industry peers. Below are selected comparisons:
| Company | Current Ratio |
|---|---|
| Zosano Pharma Corp (ZSAN) | 1.04 |
| Netmed Inc (NTME) | 33.92 |
| Check Cap Ltd (CHEK) | 18.69 |
| Rewalk Robotics Ltd (RWLK) | 15.17 |
| Scope Fluidics SA (SCP.WA) | 13.77 |
| Delcath Systems Inc (DCTH) | 12.01 |
Compared to its competitors, Zosano Pharma Corp's Current Ratio is about average compared to peers, reflecting balanced short-term asset management.